These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2530536

  • 1. [Pharmacokinetic properties of cefixime].
    Barré J.
    Presse Med; 1989 Oct 11; 18(32):1578-82. PubMed ID: 2530536
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic profile of cefixime in man.
    Faulkner RD, Yacobi A, Barone JS, Kaplan SA, Silber BM.
    Pediatr Infect Dis J; 1987 Oct 11; 6(10):963-70. PubMed ID: 3696837
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M, Wu WH, Look ZM, Silber BM, Yacobi A.
    Res Commun Chem Pathol Pharmacol; 1987 Apr 11; 56(1):21-32. PubMed ID: 3589152
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of cefixime in the young and elderly.
    Faulkner RD, Bohaychuk W, Lanc RA, Haynes JD, Desjardins RE, Yacobi A, Silber BM.
    J Antimicrob Chemother; 1988 Jun 11; 21(6):787-94. PubMed ID: 3410802
    [Abstract] [Full Text] [Related]

  • 5. [Effect of hepatic failure upon the pharmacokinetics of cefixime].
    Singlas E, Lebrec D, Gaudin C, Montay G, Roche G, Taburet AM.
    Presse Med; 1989 Oct 11; 18(32):1587-8. PubMed ID: 2530538
    [Abstract] [Full Text] [Related]

  • 6. Bioequivalency of oral suspension formulations of cefixime.
    Faulkner RD, Sia LL, Barone JS, Forbes SJ, Silber BM.
    Biopharm Drug Dispos; 1989 Oct 11; 10(2):205-11. PubMed ID: 2706319
    [Abstract] [Full Text] [Related]

  • 7. Comparative bioavailability study of cefixime administered as tablets or aqueous solution.
    Montay G, Masala F, Le Roux Y, Le Liboux A, Uhlrich J, Chassard D, Thebault JJ, Roche G, Frydman A.
    Drugs; 1991 Oct 11; 42 Suppl 4():6-9. PubMed ID: 1725153
    [Abstract] [Full Text] [Related]

  • 8. Absolute bioavailability of cefixime in man.
    Faulkner RD, Fernandez P, Lawrence G, Sia LL, Falkowski AJ, Weiss AI, Yacobi A, Silber BM.
    J Clin Pharmacol; 1988 Aug 11; 28(8):700-6. PubMed ID: 3216036
    [Abstract] [Full Text] [Related]

  • 9. Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime, in the dog.
    Bialer M, Batra VK, Morrison JA, Silber BM, Look ZM, Yacobi A.
    Pharm Res; 1987 Feb 11; 4(1):33-7. PubMed ID: 3508527
    [Abstract] [Full Text] [Related]

  • 10. [Tonsillar diffusion of cefixime in children].
    Bégué P, Garabédian N, Quinet B, Baron S.
    Presse Med; 1989 Oct 11; 18(32):1593-5. PubMed ID: 2530540
    [Abstract] [Full Text] [Related]

  • 11. [Tonsil diffusion of cefixime in children].
    Bégué P, Garabedian N, Quinet B, Baron S.
    Pathol Biol (Paris); 1989 May 11; 37(5):433-6. PubMed ID: 2780099
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].
    Kees F, Naber KG.
    Infection; 1990 May 11; 18 Suppl 3():S150-4. PubMed ID: 2079377
    [Abstract] [Full Text] [Related]

  • 13. Relationship between renal function and disposition of oral cefixime.
    Dhib M, Moulin B, Leroy A, Hameau B, Godin M, Johannides R, Fillastre JP.
    Eur J Clin Pharmacol; 1991 May 11; 41(6):579-83. PubMed ID: 1815970
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
    Mamzoridi K, Kasteridou N, Peonides A, Niopas I.
    Pharmacol Toxicol; 1996 Jun 11; 78(6):417-20. PubMed ID: 8829204
    [Abstract] [Full Text] [Related]

  • 15. Clinical pharmacology of cefixime in unweaned calves.
    Ziv G, Lavy E, Glickman A, Winkler M.
    J Vet Pharmacol Ther; 1995 Apr 11; 18(2):94-100. PubMed ID: 7629935
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency.
    Guay DR, Meatherall RC, Harding GK, Brown GR.
    Antimicrob Agents Chemother; 1986 Sep 11; 30(3):485-90. PubMed ID: 3777912
    [Abstract] [Full Text] [Related]

  • 18. Relative bioavailability of three cefixime formulations.
    Kees F, Naber KG, Sigl G, Ungethüm W, Grobecker H.
    Arzneimittelforschung; 1990 Mar 11; 40(3):293-7. PubMed ID: 2346538
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady state.
    Faulkner RD, Bohaychuk W, Desjardins RE, Look ZM, Haynes JD, Weiss AI, Silber BM.
    J Clin Pharmacol; 1987 Oct 11; 27(10):807-12. PubMed ID: 3429686
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.